Junshi wins European approval for cheaper checkpoint blocker The Pharma LetterJunshi’s toripalimab secures EC approval for NPC and ESCC treatment World Pharmaceutical FrontiersToripalimab Gains EC Approval for Cancer Treatment TipRanks
Read More…